IBB vs INDA
iShares Biotechnology ETF vs iShares MSCI India ETF
IBB$170.10
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: 0.44%Yield: 0.23%
INDA$49.82
iShares MSCI India ETF
Indian large- and mid-cap equities.
Expense: 0.61%Yield: 0.00%
Quick take
- • IBB has the lower expense ratio at 0.44% vs 0.61% for INDA.
- • IBB pays a higher dividend yield (0.23%).
Side-by-side metrics
| Metric | IBB | INDA |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.61% |
Dividend yield Trailing 12-month yield. | 0.23% | 0.00% |
AUM Assets under management — bigger funds are typically more liquid. | $7.95B | $6.59B |
YTD return | 3.10% | -7.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.74 | 0.56 |
P/E ratio | 23.72 | 21.77 |
Last price | $170.10 | $49.82 |
Inception | — | — |
Issuer | iShares | iShares |
IBB top holdings
Top holdings · IBB
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
Sector breakdown · IBB
Healthcare100.0%
INDA top holdings
Top holdings · INDA
| HDFCBANK.NS | HDFC Bank Ltd | 6.58% |
| RELIANCE.NS | Reliance Industries Ltd | 6.44% |
| ICICIBANK.NS | ICICI Bank Ltd | 4.89% |
| BHARTIARTL.NS | Bharti Airtel Ltd | 3.60% |
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 3.34% |
| INFY.NS | Infosys Ltd | 2.81% |
| AXISBANK.BO | Axis Bank Ltd | 2.21% |
| M&M.NS | Mahindra & Mahindra Ltd | 2.18% |
| LT.NS | Larsen & Toubro Ltd | 2.05% |
| 500034 | Bajaj Finance Ltd | 1.93% |
Sector breakdown · INDA
Real Estate1.4%
Consumer Cyclical12.4%
Basic Materials8.6%
Consumer Defensive6.3%
Technology8.2%
Communication Services4.6%
Financial Services28.3%
Utilities4.5%
Industrials10.3%
Energy9.4%
Healthcare6.1%
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About INDA
INDA (iShares MSCI India ETF) is Indian large- and mid-cap equities. Managed by iShares, the fund carries $6.6B in assets under management, an expense ratio of 0.61%. Its largest holding is HDFC Bank Ltd (HDFCBANK.NS), which represents 6.6% of the portfolio. Real Estate is the fund's largest sector exposure at 1.4%.